Allison Moreau

Allison Moreau is currently the Late Development Clinical Sciences TA Head in GU Oncology at Pfizer. They have previously held positions at Bristol-Myers Squibb as a Senior Scientist in Exploratory Clinical & Translational Research in Immuno-Oncology and at Merck as a Senior Clinical Scientist and Sr. Regulatory Scientist. They have also served in various roles at Pfizer, including Director of Clinician and Associate Director of Oncology Study Management. Allison is pursuing a Master of Public Health at Rutgers University, along with a Master of Science from Wagner College, while also attending North Carolina State University.